Status:
COMPLETED
The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Endometriosis
Sexual Dysfunction
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study aimed to assess the effects of dydrogesterone on sexual function in women with endometriosis using Female Function Sexual Index (FSFI).
Detailed Description
Sexual dysfunction is an important outcome for patients with endometriosis. In this study, we compare the fsfi (female sexual function index) questions and the scores before and after dydrogesterone t...
Eligibility Criteria
Inclusion
- no history of malignancies,
- normal findings at gynecological examinations and transvaginal ultrasonography
- normal uterine size, normal cervical smear results,
- patients not use any contraception methods in the last 6 months
Exclusion
- with a history of systemic and/or psychiatric diseases,
- gynecological pathologies (myoma uteri, endometriosis, uterine anomalies, existing genital infections)
- pelvic organ prolapse
- pelvic surgeries
Key Trial Info
Start Date :
April 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2020
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT04287205
Start Date
April 20 2019
End Date
March 3 2020
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye), 34000